Alloimmune responses and atherosclerotic disease after kidney transplantation.
Didier Ducloux, Cécile Courivaud, Jamal Bamoulid, Vincent Bisaccia, Caroline Roubiou, Thomas Crepin, Béatrice Gaugler, Caroline Laheurte, Jean-Michel Rebibou, Jean-Marc Chalopin, Philippe Saas
Index: Transplantation 99(1) , 220-5, (2014)
Full Text: HTML
Abstract
Chronic exposure to exogenous antigens causes accumulation of proinflammatory CD57(+)CD28(-) hyperactivated CD8(+) T cells that may promote atherosclerosis. We hypothesized that persistent alloimmune responses may induce immune activation and contribute to posttransplant atherosclerosis.This hypothesis was tested in a single-center cohort of 577 kidney transplant patients. Propensity score analysis was performed to address potential confounding variables by indication. Immune exhaustion was studied in subcohort of 103 patients.Five hundred seventy-seven consecutive renal transplant recipients were included. Seventy-seven atherosclerotic events (AE) (12.3%) occurred during a mean follow-up of 7 years. The cumulative incidence of AE increased with the number of human leukocyte antigen (HLA) mismatches (18%, 10%, and 5% in patients with 5-6, 3-4, and 0-2 mismatches, respectively; P=0.012). Human leukocyte antigen mismatch number (hazards ratio, 1.35; 95% confidence interval, 1.10-1.66, for each supplementary mismatch; P=0.005) was an independent risk factor for AE. In the propensity score match analysis, having received a well-matched kidney conferred a reduced risk of AE (hazards ratio, 0.22; 95% confidence interval, 0.05-0.95; P=0.044). We observed a significant correlation between HLA mismatch numbers and circulating CD57(+)CD28(-) CD8(+) T cells (R=0.31; P=0.017). These CD8(+) T cells were more frequent in patients with more HLA mismatches (P<0.0001).Overall, our results suggest that chronic allogeneic stimulation participates to accelerated atherosclerosis observed after transplantation.
Related Compounds
Related Articles:
2014-12-01
[Plast. Reconstr. Surg. 134(6) , 1213-23, (2014)]
2014-09-01
[Am. J. Physiol. Cell Physiol. 307(5) , C479-92, (2014)]
2014-09-01
[Arch. Toxicol. 88(9) , 1695-709, (2014)]
2014-01-01
[PLoS ONE 9(11) , e112413, (2014)]
2014-09-01
[Cell Biochem. Biophys. 70(1) , 367-81, (2014)]